Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
29.24
-0.34 (-1.15%)
Mar 30, 2026, 3:00 PM CST
SHA:688639 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 284.12 | 422.64 | 352.98 | 147.46 | 121.79 |
Trading Asset Securities | - | - | - | 200.31 | 341.06 |
Cash & Short-Term Investments | 284.12 | 422.64 | 352.98 | 347.78 | 462.85 |
Cash Growth | -32.77% | 19.73% | 1.50% | -24.86% | 644.14% |
Accounts Receivable | 416.78 | 374.28 | 318.43 | 326.39 | 222.79 |
Other Receivables | 11.89 | 16.48 | 10.47 | 13.56 | 12.03 |
Receivables | 428.67 | 390.76 | 328.89 | 339.95 | 234.82 |
Inventory | 532.13 | 406.92 | 226.46 | 135.51 | 106.21 |
Other Current Assets | 219.16 | 131.43 | 141.7 | 39.81 | 48.62 |
Total Current Assets | 1,464 | 1,352 | 1,050 | 863.06 | 852.5 |
Property, Plant & Equipment | 3,844 | 3,213 | 2,620 | 951.83 | 528.43 |
Long-Term Investments | 124.45 | 123.45 | 112.4 | 40 | 7 |
Other Intangible Assets | 150.04 | 137.73 | 86.28 | 73.17 | 43.98 |
Long-Term Deferred Tax Assets | 145.3 | 86.54 | 49.39 | 40.48 | 14.39 |
Long-Term Deferred Charges | 13.64 | 5.79 | - | - | - |
Other Long-Term Assets | 33.51 | 71.17 | 51.9 | 58.54 | 27.8 |
Total Assets | 5,775 | 4,989 | 3,970 | 2,027 | 1,474 |
Accounts Payable | 712.68 | 564.03 | 589.01 | 221.64 | 99.87 |
Accrued Expenses | 52.07 | 44 | 36.87 | 35.06 | 17.95 |
Short-Term Debt | 123.38 | 681.98 | 915.12 | 79.23 | 18.5 |
Current Portion of Long-Term Debt | 363.03 | 225.75 | 26.6 | - | - |
Current Income Taxes Payable | 3.58 | 4.92 | 25.5 | 5.32 | 6.67 |
Current Unearned Revenue | 17 | 17.4 | 12.77 | 19.61 | 17.57 |
Other Current Liabilities | 67.59 | 65.45 | 70.61 | 27.9 | 22.34 |
Total Current Liabilities | 1,339 | 1,604 | 1,676 | 388.75 | 182.89 |
Long-Term Debt | 1,572 | 637.81 | 304.93 | - | - |
Long-Term Unearned Revenue | 94.75 | 87.62 | 91.53 | 102.63 | 86.23 |
Long-Term Deferred Tax Liabilities | 136.32 | 102.07 | 71.64 | 54.05 | 21.85 |
Total Liabilities | 3,143 | 2,431 | 2,145 | 545.44 | 290.98 |
Common Stock | 250.12 | 249.72 | 157.54 | 108.4 | 108.4 |
Additional Paid-In Capital | 1,218 | 1,209 | 603.46 | 624.47 | 588.04 |
Retained Earnings | 1,228 | 1,158 | 1,110 | 758.99 | 498.69 |
Treasury Stock | -50.01 | -53.61 | -45.24 | -12 | -12 |
Comprehensive Income & Other | 0.43 | 0.96 | 0.72 | 0.64 | - |
Total Common Equity | 2,647 | 2,565 | 1,827 | 1,480 | 1,183 |
Minority Interest | -14.82 | -6.27 | -1.31 | 1.15 | - |
Shareholders' Equity | 2,632 | 2,558 | 1,826 | 1,482 | 1,183 |
Total Liabilities & Equity | 5,775 | 4,989 | 3,970 | 2,027 | 1,474 |
Total Debt | 2,059 | 1,546 | 1,247 | 79.23 | 18.5 |
Net Cash (Debt) | -1,775 | -1,123 | -893.67 | 268.55 | 444.35 |
Net Cash Growth | - | - | - | -39.56% | 6128.38% |
Net Cash Per Share | -7.10 | -4.86 | -3.90 | 1.18 | 2.14 |
Filing Date Shares Outstanding | 248.79 | 235.72 | 227.71 | 227.91 | 227.91 |
Total Common Shares Outstanding | 248.79 | 235.72 | 227.71 | 227.91 | 227.91 |
Working Capital | 124.76 | -251.78 | -626.43 | 474.3 | 669.61 |
Book Value Per Share | 10.64 | 10.88 | 8.02 | 6.50 | 5.19 |
Tangible Book Value | 2,497 | 2,427 | 1,741 | 1,407 | 1,139 |
Tangible Book Value Per Share | 10.04 | 10.30 | 7.64 | 6.17 | 5.00 |
Buildings | 862.98 | 755.99 | 462.42 | 290.67 | 200.66 |
Machinery | 2,449 | 1,307 | 952.21 | 703.78 | 439.11 |
Construction In Progress | 1,192 | 1,606 | 1,529 | 188.91 | 65.33 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.